Cosmos Health (COSM) to Release Quarterly Earnings on Monday

Cosmos Health (NASDAQ:COSM) is expected to issue its results before the market opens on Monday, August 17th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $19.42 million for the quarter.

Cosmos Health (NASDAQ:COSM) last issued its earnings results on Wednesday, May 20th. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.06). The company had revenue of $18.40 million for the quarter, compared to analysts’ expectations of $17.93 million. Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. On average, analysts expect Cosmos Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cosmos Health Price Performance

NASDAQ:COSM opened at $0.23 on Monday. The company has a quick ratio of 0.92, a current ratio of 1.08 and a debt-to-equity ratio of 0.31. The stock’s 50 day moving average price is $0.23 and its two-hundred day moving average price is $0.32. The firm has a market capitalization of $13.99 million, a price-to-earnings ratio of -0.36 and a beta of 4.80. Cosmos Health has a 12-month low of $0.16 and a 12-month high of $1.32.

Insider Buying and Selling

In other news, CFO Georgios Terzis purchased 168,135 shares of the company’s stock in a transaction that occurred on Tuesday, June 16th. The stock was acquired at an average cost of $0.25 per share, with a total value of $42,033.75. Following the acquisition, the chief financial officer owned 2,235,398 shares in the company, valued at approximately $558,849.50. This trade represents a 8.13% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Grigorios Siokas purchased 349,825 shares of Cosmos Health stock in a transaction that occurred on Thursday, July 30th. The stock was purchased at an average price of $0.20 per share, with a total value of $69,965.00. Following the completion of the purchase, the chief executive officer directly owned 14,597,917 shares in the company, valued at $2,919,583.40. This trade represents a 2.46% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have bought 2,204,138 shares of company stock valued at $457,137. Corporate insiders own 26.15% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in COSM. Citadel Advisors LLC grew its stake in shares of Cosmos Health by 133.1% in the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after acquiring an additional 128,776 shares in the last quarter. Renaissance Technologies LLC increased its position in Cosmos Health by 260.5% during the fourth quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock worth $167,000 after acquiring an additional 241,775 shares during the period. Finally, XTX Topco Ltd boosted its holdings in Cosmos Health by 52.1% in the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after purchasing an additional 34,117 shares during the period. 12.61% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded Cosmos Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 30th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.